Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
MSF Access Campaign Although @GileadSciences publicised their pledge to reduce the price of the drug L-AmB to a ‘no-profit’ price of US$16.25 per vial in September 2018, the drug continues to be mostly unavailable or priced out of reach in developing countries. Read more 23:45 - 06 Sep 2019